PRODUCTS
SERVICES
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
2.06
1 yrs 9 m
1%
1,786.18 Crs
1% on or before 30D, Nil after 30D
Large Growth
7.71
SIP 100 & Lumpsum 100
NA
Nikhil Mathur
Investors understand that their principal will be at very high risk